The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, ...

April 27 (Reuters) - Medical equipment maker Thermo Fisher Scientific said on Monday it would sell its microbiology business ...

Thermo Fisher Scientific Inc. agreed to sell its microbiology business to Astorg, a private equity firm, for approximately $1.075 billion, consisting of cash and a $50 million seller note. The ...

Veterinary practices are adopting integrated diagnostic systems that link in-house and reference labs with practice management software to deliver faster, more accurate results. This connectivity ...

Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about ...

The unit generated $645 million in revenue in 2025 and supplies products used in clinical, pharmaceutical, and food safety ...

A drug-resistant Salmonella strain linked to backyard flocks has hospitalised dozens across 13 states, with nearly half the ...

The 510(k) clearances were granted to a dozen in vitro diagnostic tests and reagents which used a variety of detection methods and approaches.

Thermo Fisher Scientific is shedding its microbiology business to private equity firm Astorg nearly a year after initial ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has signed a ...

Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about $1.075 billion. Thermo Fisher on Monday said the microbiology business, ...

The private equity group plans to accelerate growth of the acquired business, including by empowering it to engage in M&A.